v3.26.1
Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2024 $ 469,852 $ 53 $ 660,604 $ (190,780) $ (25)
Beginning balance, shares at Dec. 31, 2024   53,603,398      
Issuance of common stock upon exercise of stock options, shares   37,497      
Stock-based compensation expense 2,635   2,635    
Unrealized gain (loss) on available-for-sale securities, net of tax 393       393
Net loss (27,270)     (27,270)  
Ending balance at Mar. 31, 2025 445,610 $ 53 663,239 (218,050) 368
Ending balance, shares at Mar. 31, 2025   53,640,895      
Beginning balance at Dec. 31, 2025 339,771 $ 54 673,410 (334,223) 530
Beginning balance, shares at Dec. 31, 2025   54,237,750      
Issuance of common stock upon exercise of stock options 598   598    
Issuance of common stock upon exercise of stock options, shares   159,331      
Vesting of restricted stock units, shares   22,905      
Stock-based compensation expense 4,647   4,647    
Unrealized gain (loss) on available-for-sale securities, net of tax (430)       (430)
Net loss (40,591)     (40,591)  
Ending balance at Mar. 31, 2026 $ 303,995 $ 54 $ 678,655 $ (374,814) $ 100
Ending balance, shares at Mar. 31, 2026   54,419,986